Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01320748 · ClinicalTrials.gov registry record · NA

fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults

A NA study, sponsored by Inova Health Care Services.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT01320748 is a NA study that has completed, run by Inova Health Care Services. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01320748, a NA study, has completed, sponsored by Inova Health Care Services.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether drug-dependent adults who participate in a dual processing relapse prevention treatment protocol that allows for sensory-based exposure experiences over 10-weeks in outpatient treatment will show significant brain change related to diminished cue reactivity, and greater improvement in self-efficacy, anxiety, somatization, and treatment retention, as compared to the standard care patients in a relapse prevention program.

Interventions

  • BEHAVIORAL Relapse Prevention
  • BEHAVIORAL Dual Processing

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2011-02
Est. Completion 2013-01
Phase NA

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT01320748

The ClinicalTrials.gov registry entry for NCT01320748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Relapse Prevention is the first listed.

NCT01320748 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01320748 about?

NCT01320748 is a clinical study titled "fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults". The purpose of this study is to determine whether drug-dependent adults who participate in a dual processing relapse prevention treatment protocol that allows for sensory-based exposure experiences over 10-weeks in outpatient treatment will show significant brain change related to diminished cue rea...

What is the current status of trial NCT01320748?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2011-02. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01320748?

The interventions under investigation include: Relapse Prevention (BEHAVIORAL), Dual Processing (BEHAVIORAL).

Who is sponsoring clinical trial NCT01320748?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.